Hubei Jumpcan Pharmaceutical Statistics

Total Valuation

Hubei Jumpcan Pharmaceutical has a market cap or net worth of CNY 25.38 billion. The enterprise value is 15.12 billion.

Market Cap	25.38B
Enterprise Value	15.12B

Important Dates

The next estimated earnings date is Wednesday, October 23, 2024.

Earnings Date	Oct 23, 2024
Ex-Dividend Date	Jun 17, 2024

Share Statistics

Hubei Jumpcan Pharmaceutical has 921.70 million shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding	921.70M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	+0.91%
Owned by Insiders (%)	5.25%
Owned by Institutions (%)	12.54%
Float	340.37M

Valuation Ratios

The trailing PE ratio is 8.97 and the forward PE ratio is 8.33.

PE Ratio	8.97
Forward PE	8.33
PS Ratio	2.79
PB Ratio	1.88
P/FCF Ratio	9.95
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.98, with an EV/FCF ratio of 5.92.

EV / Earnings	5.36
EV / Sales	1.67
EV / EBITDA	4.98
EV / EBIT	5.52
EV / FCF	5.92

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 10.00.

Current Ratio	3.29
Quick Ratio	3.12
Debt / Equity	10.00
Debt / EBITDA	0.45
Debt / FCF	0.53
Interest Coverage	101.83

Financial Efficiency

Return on equity (ROE) is 22.23% and return on invested capital (ROIC) is 12.52%.

Return on Equity (ROE)	22.23%
Return on Assets (ROA)	9.94%
Return on Capital (ROIC)	12.52%
Revenue Per Employee	1.73M
Profits Per Employee	539,435
Employee Count	5,230
Asset Turnover	0.53
Inventory Turnover	2.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.08% in the last 52 weeks. The beta is 0.14, so Hubei Jumpcan Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+7.08%
50-Day Moving Average	31.66
200-Day Moving Average	34.42
Relative Strength Index (RSI)	31.05
Average Volume (20 Days)	8,947,661

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hubei Jumpcan Pharmaceutical had revenue of CNY 9.06 billion and earned 2.82 billion in profits. Earnings per share was 3.07.

Revenue	9.06B
Gross Profit	7.30B
Operating Income	2.74B
Pretax Income	3.30B
Net Income	2.82B
EBITDA	3.03B
EBIT	2.74B
Earnings Per Share (EPS)	3.07

Full Income Statement

Balance Sheet

The company has 11.64 billion in cash and 1.35 billion in debt, giving a net cash position of 10.29 billion or 11.16 per share.

Cash & Cash Equivalents	11.64B
Total Debt	1.35B
Net Cash	10.29B
Net Cash Per Share	11.16
Equity (Book Value)	13.53B
Book Value Per Share	14.65
Working Capital	9.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.83 billion and capital expenditures -280.63 million, giving a free cash flow of 2.55 billion.

Operating Cash Flow	2.83B
Capital Expenditures	-280.63M
Free Cash Flow	2.55B
FCF Per Share	2.77

Full Cash Flow Statement

Margins

Gross margin is 80.60%, with operating and profit margins of 30.24% and 31.14%.

Gross Margin	80.60%
Operating Margin	30.24%
Pretax Margin	36.45%
Profit Margin	31.14%
EBITDA Margin	33.48%
EBIT Margin	30.24%
FCF Margin	28.17%

Dividends & Yields

This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 4.72%.

Dividend Per Share	1.30
Dividend Yield	4.72%
Dividend Growth (YoY)	47.73%
Years of Dividend Growth	2
Payout Ratio	60.44%
Buyback Yield	-0.24%
Shareholder Yield	4.49%
Earnings Yield	11.15%
FCF Yield	10.05%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a